Participants:18–64 years · 65+ years
Substances:N2-(3-(2-(2H-1,2,3-Triazol-2-Yl)Propan-2-Yl)-1-Cyclopropyl-1H-Pyrazol-5-Yl)-N4-Ethyl-5-(Trifluoromethyl)Pyrimidine-2,4-Diamine

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study of Atezolizumab and Bevacizumab for Patients with High-Risk Hepatocellular Carcinoma After Surgery or Ablation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

InvestigationalNo placebo

Study of Davutamig (REGN5093) for Patients with Advanced Non-Small Cell Lung Cancer with MET Alterations

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Davutamig

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease

Investigational

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Hormone-dependent prostate cancer

Not recruiting

Registered drug

Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Breast cancer female

Not recruiting

Registered drugNo placebo

Study on Infertility Risk from Chemotherapy in Young Breast Cancer Patients Using Follitropin Beta and Follitropin Alfa for Egg/Embryo Preservation

Registered drugNo placebo

France

Participants:18–64 years
Substances:Follitropin Alfa

Contact Research Centre

Multiple sclerosis relapse

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Tolerability of Ofatumumab Compared to a Drug Combination for Patients with Newly Diagnosed Relapsing Multiple Sclerosis

Registered drugNo placebo

France

Participants:18–64 years
Substances:Dimethyl Fumarate

Contact Research Centre

Fungal infection

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Olorofim vs. Liposomal Amphotericin B for Patients with Invasive Aspergillosis

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Olorofim

Contact Research Centre

Find therapies in clinical trials near you – page 64

865 trials match your criteria

Hormone receptor positive HER2 negative breast cancer

Study of palbociclib with hormone therapy guided by ESR1 mutation monitoring in patients with ER-positive, HER2-negative metastatic breast cancer

Non-small cell lung cancer

Study on the Effectiveness and Safety of Alectinib, Entrectinib, and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Paroxysmal nocturnal haemoglobinuria

Study Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors

Chronic lymphocytic leukaemia

Study of Pirtobrutinib, Venetoclax and Rituximab combination compared to Venetoclax and Rituximab in previously treated Chronic Lymphocytic Leukemia patients

Parkinson's disease

Study on the Effectiveness and Safety of BIIB122 for Patients with Parkinson's Disease

Hepatocellular carcinoma

Study of Atezolizumab and Bevacizumab for Patients with High-Risk Hepatocellular Carcinoma After Surgery or Ablation

Non-small cell lung cancer

Study of Davutamig (REGN5093) for Patients with Advanced Non-Small Cell Lung Cancer with MET Alterations

Crohn's disease

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease

Hormone-dependent prostate cancer

Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

Breast cancer female

Study on Infertility Risk from Chemotherapy in Young Breast Cancer Patients Using Follitropin Beta and Follitropin Alfa for Egg/Embryo Preservation

Multiple sclerosis relapse

Study on the Effectiveness and Tolerability of Ofatumumab Compared to a Drug Combination for Patients with Newly Diagnosed Relapsing Multiple Sclerosis

Fungal infection

Study on the Effectiveness and Safety of Olorofim vs. Liposomal Amphotericin B for Patients with Invasive Aspergillosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.